- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN0651 | Recombinant Protein-Human adenovirus B 42.3 kDa protein (a.a.21 to 373) | Q1L442 | 100 µg | 1195 | |
PN0652 | Recombinant Protein-Human adenovirus B 57.5 kDa DNA-binding protein (a.a.51 to 518) | Q5UW06 | 100 µg | 1195 | |
PN0653 | Recombinant Protein-Human adenovirus B 70.9 kDa preterminal protein (a.a.51 to 638) | Q5UW16 | 100 µg | 1195 | |
PN0654 | Recombinant Protein-Human adenovirus B serotype 16 13.9 kDa protein (a.a.21 to 125) | Q2KRU6 | 100 µg | 1195 | |
PN0655 | Recombinant Protein-Human adenovirus B serotype 16 13.6 kDa protein (a.a.21 to 122) | Q2KRV0 | 100 µg | 1195 | |
PN0656 | Recombinant Protein-Human adenovirus B serotype 16 34 kDa protein (a.a.21 to 298) | Q2KRV1 | 100 µg | 1195 | |
PN0657 | Recombinant Protein-Human adenovirus B serotype 16 33 kDa protein (a.a.21 to 234) | Q2KRW6 | 100 µg | 1195 | |
PN0658 | Recombinant Protein-Human adenovirus B serotype 16 23 kDa protease (a.a.21 to 209) | Q2KRW9 | 100 µg | 1195 | |
PN0659 | Recombinant Protein-Human adenovirus B serotype 16 E3 14.9kDa protein (a.a.36 to 146) | Q91CJ9 | 100 µg | 1195 | |
PN0660 | Recombinant Protein-Human adenovirus B serotype 16 16.1 kDa membrane protein (E3 16.1kDa protein) (a.a.23 to 146) | Q91CK5 | 100 µg | 1195 | |
PN0661 | Recombinant Protein-Human adenovirus B serotype 3 11 kDa protein (a.a.21 to 117) | Q2KSI7 | 100 µg | 1195 | |
PN0662 | Recombinant Protein-Human adenovirus B serotype 3 9.7 kDa protein (a.a.21 to 91) | Q2KSK2 | 100 µg | 1195 | |
PN0663 | Recombinant Protein-Human adenovirus B serotype 3 11.3 kDa protein (a.a.37 to 104) | Q2KSK3 | 100 µg | 1195 | |
PN0664 | Recombinant Protein-Human adenovirus B serotype 3 55 kDa protein (a.a.21 to 378) | Q2KSU3 | 100 µg | 1195 | |
PN0665 | Recombinant Protein-Human adenovirus B serotype 3 14 kDa protein (a.a.21 to 136) | Q2Y0F9 | 100 µg | 1195 | |
PN0666 | Recombinant Protein-Human adenovirus B serotype 3 20.1 kDa protein (a.a.21 to 189) | Q2Y0G3 | 100 µg | 1195 | |
PN0667 | Recombinant Protein-Human adenovirus B serotype 3 L2 protein pVII (a.a.71 to 192) | Q2Y0H8 | 100 µg | 1195 | |
PN0668 | Recombinant Protein-Human adenovirus B serotype 3 19 kDa protein (a.a.47 to 173) | Q2Y0I6 | 100 µg | 1195 | |
PN0669 | Recombinant Protein-Human adenovirus B serotype 3 E1B 55-kDa Large T antigen (a.a.46 to 492) | Q2Y0J2 | 100 µg | 1195 | |
PN0670 | Recombinant Protein-Human adenovirus B serotype 35 52.55K protein (a.a.21 to 388) | Q6YL77 | 100 µg | 1195 | |
PN0671 | Recombinant Protein-Human adenovirus B serotype 35 E4 122R protein (a.a.28 to 122) | Q7T923 | 100 µg | 1195 | |
PN0672 | Recombinant Protein-Human adenovirus B serotype 35 23K protein (a.a.21 to 209) | Q7T935 | 100 µg | 1195 | |
PN0673 | Recombinant Protein-Human adenovirus B E1a 230R protein (a.a.31 to 231) | Q7T953 | 100 µg | 1195 | |
PN0674 | Recombinant Protein-Human adenovirus B E1a 261R protein (a.a.31 to 262) | Q7T954 | 100 µg | 1195 | |
PN0675 | Recombinant Protein-Human adenovirus B serotype 35 15.2 kDa protein (a.a.22 to 134) | Q67731 | 100 µg | 1195 | |
PN0676 | Recombinant Protein-Human adenovirus B serotype 7 130aa protein (a.a.21 to 129) | Q2KS43 | 100 µg | 1195 | |
PN0677 | Recombinant Protein-Human adenovirus B serotype 7 13.6 kDa agnoprotein (a.a.46 to 198) | Q4JEP6 | 100 µg | 1195 | |
PN0678 | Recombinant Protein-Human adenovirus B serotype 7 E2B hypothetical 12.6 kDa early protein (a.a.21 to 114) | Q5EY75 | 100 µg | 1195 | |
PN0679 | Recombinant Protein-Human adenovirus B serotype 7 E1A protein (a.a.21 to 145) | Q5YKW5 | 100 µg | 1195 | |
PN0680 | Recombinant Protein-Human adenovirus B serotype 7 L2 protein V (a.a.21 to 350) | Q6RK89 | 100 µg | 1195 | |
PN0681 | Recombinant Protein-Human adenovirus B serotype 7 14.9 kDa protein (a.a.50 to 116) | Q99I45 | 100 µg | 1195 | |
PN0682 | Recombinant Protein-Human adenovirus B serotype 7 Protein VIII (a.a.21 to 197) | Q2KS32 | 100 µg | 1195 | |
RPN0651 | cDNA-Human adenovirus B 42.3 kDa protein (a.a.21 to 373) | Q1L442 | 2 µg | 1760 | |
RPN0652 | cDNA-Human adenovirus B 57.5 kDa DNA-binding protein (a.a.51 to 518) | Q5UW06 | 2 µg | 2335 | |
RPN0653 | cDNA-Human adenovirus B 70.9 kDa preterminal protein (a.a.51 to 638) | Q5UW16 | 2 µg | 2935 | |
RPN0654 | cDNA-Human adenovirus B serotype 16 13.9 kDa protein (a.a.21 to 125) | Q2KRU6 | 2 µg | 800 | |
RPN0655 | cDNA-Human adenovirus B serotype 16 13.6 kDa protein (a.a.21 to 122) | Q2KRV0 | 2 µg | 800 | |
RPN0656 | cDNA-Human adenovirus B serotype 16 34 kDa protein (a.a.21 to 298) | Q2KRV1 | 2 µg | 1385 | |
RPN0657 | cDNA-Human adenovirus B serotype 16 33 kDa protein (a.a.21 to 234) | Q2KRW6 | 2 µg | 1065 | |
RPN0658 | cDNA-Human adenovirus B serotype 16 23 kDa protease (a.a.21 to 209) | Q2KRW9 | 2 µg | 940 | |
RPN0659 | cDNA-Human adenovirus B serotype 16 E3 14.9kDa protein (a.a.36 to 146) | Q91CJ9 | 2 µg | 800 | |
RPN0660 | cDNA-Human adenovirus B serotype 16 16.1 kDa membrane protein (E3 16.1kDa protein) (a.a.23 to 146) | Q91CK5 | 2 µg | 800 | |
RPN0661 | cDNA-Human adenovirus B serotype 3 11 kDa protein (a.a.21 to 117) | Q2KSI7 | 2 µg | 800 | |
RPN0662 | cDNA-Human adenovirus B serotype 3 9.7 kDa protein (a.a.21 to 91) | Q2KSK2 | 2 µg | 800 | |
RPN0663 | cDNA-Human adenovirus B serotype 3 11.3 kDa protein (a.a.37 to 104) | Q2KSK3 | 2 µg | 800 | |
RPN0664 | cDNA-Human adenovirus B serotype 3 55 kDa protein (a.a.21 to 378) | Q2KSU3 | 2 µg | 1785 | |
RPN0665 | cDNA-Human adenovirus B serotype 3 14 kDa protein (a.a.21 to 136) | Q2Y0F9 | 2 µg | 800 | |
RPN0666 | cDNA-Human adenovirus B serotype 3 20.1 kDa protein (a.a.21 to 189) | Q2Y0G3 | 2 µg | 840 | |
RPN0667 | cDNA-Human adenovirus B serotype 3 L2 protein pVII (a.a.71 to 192) | Q2Y0H8 | 2 µg | 800 | |
RPN0668 | cDNA-Human adenovirus B serotype 3 19 kDa protein (a.a.47 to 173) | Q2Y0I6 | 2 µg | 800 | |
RPN0669 | cDNA-Human adenovirus B serotype 3 E1B 55-kDa Large T antigen (a.a.46 to 492) | Q2Y0J2 | 2 µg | 2230 | |
RPN0670 | cDNA-Human adenovirus B serotype 35 52.55K protein (a.a.21 to 388) | Q6YL77 | 2 µg | 1835 | |
RPN0671 | cDNA-Human adenovirus B serotype 35 E4 122R protein (a.a.28 to 122) | Q7T923 | 2 µg | 800 | |
RPN0672 | cDNA-Human adenovirus B serotype 35 23K protein (a.a.21 to 209) | Q7T935 | 2 µg | 940 | |
RPN0673 | cDNA-Human adenovirus B E1a 230R protein (a.a.31 to 231) | Q7T953 | 2 µg | 1000 | |
RPN0674 | cDNA-Human adenovirus B E1a 261R protein (a.a.31 to 262) | Q7T954 | 2 µg | 1155 | |
RPN0675 | cDNA-Human adenovirus B serotype 35 15.2 kDa protein (a.a.22 to 134) | Q67731 | 2 µg | 800 | |
RPN0676 | cDNA-Human adenovirus B serotype 7 130aa protein (a.a.21 to 129) | Q2KS43 | 2 µg | 800 | |
RPN0677 | cDNA-Human adenovirus B serotype 7 13.6 kDa agnoprotein (a.a.46 to 198) | Q4JEP6 | 2 µg | 760 | |
RPN0678 | cDNA-Human adenovirus B serotype 7 E2B hypothetical 12.6 kDa early protein (a.a.21 to 114) | Q5EY75 | 2 µg | 800 | |
RPN0679 | cDNA-Human adenovirus B serotype 7 E1A protein (a.a.21 to 145) | Q5YKW5 | 2 µg | 800 | |
RPN0680 | cDNA-Human adenovirus B serotype 7 L2 protein V (a.a.21 to 350) | Q6RK89 | 2 µg | 1645 | |
RPN0681 | cDNA-Human adenovirus B serotype 7 14.9 kDa protein (a.a.50 to 116) | Q99I45 | 2 µg | 800 | |
RPN0682 | cDNA-Human adenovirus B serotype 7 Protein VIII (a.a.21 to 197) | Q2KS32 | 2 µg | 880 |
Human adenovirus B cDNA and recombinant antigen
Human adenovirus B is a type of adenovirus that can cause a range of illnesses in humans, including respiratory infections, eye infections, and gastroenteritis. Some adenovirus B strains can also cause more serious illnesses, such as meningitis or pneumonia. The virus spreads through close contact with an infected person or through contact with contaminated surfaces. There is no specific cure for adenovirus infections, but symptoms can be managed with rest, hydration, and over-the-counter medications. Like all adenoviruses, human adenovirus B can infect a wide range of host cells and cause a variety of symptoms depending on the host’s age, immune status, and the specific strain of the virus.
Adenovirus B antigen refers to a substance produced by a human adenovirus B infection that can be detected in a laboratory test. The presence of adenovirus B antigens indicates that a person is infected with the virus. Antigen tests are commonly used to diagnose adenovirus infections, as well as to monitor the progression of the infection and to determine whether a patient is no longer contagious. These tests work by detecting proteins on the surface of the virus, and they are generally quick, simple, and highly accurate. In the case of human adenovirus B, the specific antigen used in the test will depend on the specific strain of the virus that is causing the infection.
Human adenovirus B is a type of adenovirus that infects humans. It contains various proteins that are important for the virus’s life cycle and interaction with host cells. Some of the notable proteins of human adenovirus B include:
42.3 kDa protein: a non-structural protein that is involved in viral DNA replication.
57.5 kDa DNA-binding protein: a structural protein that binds to viral DNA and helps to package it into the viral particle.
70.9 kDa preterminal protein: a non-structural protein that is involved in the initiation of viral DNA replication.
Serotype 16 13.9 kDa protein (13.6 kDa,13.6 kDa,33 kDa, 34 kDa, 23 kDa, E3 14.9kDa, E3 16.1kDa): a group of non-structural and structural proteins that are involved in viral replication and assembly.
Serotype 3 (11 kDa, 9.7 kDa, 11.3 kDa, 55 kDa, 14 kDa) protein: a group of non-structural and structural proteins that play important roles in viral replication and assembly.
pVII: a structural protein that is a component of the viral capsid.
E1B 55-kDa Large T antigen: a multifunctional protein that plays a key role in viral replication and transformation of infected cells.
E4 122R protein: a non-structural protein that is involved in the inhibition of host cell apoptosis.
E1a 230R protein and E1a 261R protein: non-structural proteins that regulate the expression of viral and cellular genes.
E2B hypothetical 12.6 kDa early protein: a non-structural protein that is involved in viral DNA replication.
E1A protein: a transcriptional activator that regulates the expression of both viral and cellular genes.
L2 protein of serotype 7 and Protein VIII: structural proteins that are components of the viral capsid.
These proteins work together to allow the adenovirus to enter host cells, replicate its genetic material, produce new viral particles, and evade the host’s immune response. Understanding the roles of these proteins is important for the development of effective antiviral treatments and vaccines.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E.coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple
